Skip to Content
Skip to Content

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 29 October 2019. Database contains 224 unique substances/entries.
Filter the list
Latest update:
Date of intention:
Date of RMOA conclusion:

 
603-051-2
125304-04-3
Germany
Bioaccumulation
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
01/04/2015
Details
205-031-5
131-57-7
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
01/04/2015
Details
215-181-3
1310-58-3
Sweden
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
Other
08/04/2015
Details
215-185-5
1310-73-2
Sweden
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
Other
08/04/2015
Details
220-239-6
2682-20-4
Denmark
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
04/05/2015
Details
235-921-9
13048-33-4
Sweden
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
04/05/2015
Details
show/hide
perfluorononan-1-oic acid ammonium salts EC / List no: - | CAS no: 4149-60-4
Perfluorononan-1-oic acid EC / List no: 206-801-3 | CAS no: 375-95-1
perfluorononan-1-oic acid sodium salts EC / List no: - | CAS no: 21049-39-8
-
-
Sweden
Bioaccumulation
Carcinogenic
Mutagenic
Other environmental toxicity
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
04/05/2015
Details
250-863-4
31906-04-4
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
05/06/2015
Details
202-716-0
98-95-3
Austria
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
03/07/2015
Details
253-242-6
36861-47-9
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
3-benzylidene camphor; 3-BC
239-139-9
15087-24-8
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
219-154-7
2374-14-3
Netherlands
Bioaccumulation
Other human toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
CLH
10/07/2015
Details
223-383-8
3864-99-1
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
253-037-1
36437-37-3
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
212-039-2
753-73-1
Netherlands
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
10/07/2015
Details
202-051-6
91-22-5
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/07/2015
Details
203-444-5
106-93-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
Other legislation
07/08/2015
Details
D5
208-764-9
541-02-6
United Kingdom
Bioaccumulation
Other environmental toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/08/2015
Details
D4
209-136-7
556-67-2
United Kingdom
Bioaccumulation
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/08/2015
Details
DCHP
201-545-9
84-61-7
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/09/2015
Details
210-658-2
620-92-8
Sweden
Endocrine disruption
Other human toxicity
Under development
Under development
No suggestion yet
01/10/2015
Details
215-271-2
1317-40-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
08/10/2015
Details
201-469-6
83-32-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
11/12/2015
Details
-
-
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
11/12/2015
Details
show/hide
Lead EC / List no: 231-100-4 | CAS no: 7439-92-1
Lead compounds EC / List no: - | CAS no: -
-
-
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
04/02/2016
Details
226-378-9
5384-21-4
France
Endocrine disruption
Persistence
Toxic for reproduction
Widespread use
Under development
Under development
No suggestion yet
11/03/2016
Details
trimellitic anhydride; TMA
209-008-0
552-30-7
Netherlands
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
11/03/2016
Details
431-890-2
-
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
15/03/2016
Details
200-652-8
67-43-6
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
01/04/2016
Details
205-391-3
140-01-2
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
01/04/2016
Details
231-512-4
7601-90-3
Germany
Endocrine disruption
Under development
Under development
No suggestion yet
13/06/2016
Details
213-934-0
1067-53-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
13/06/2016
Details
200-659-6
67-56-1
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
08/07/2016
Details
276-743-1
72624-02-3
Austria
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
19/07/2016
Details
200-001-8
50-00-0
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
911-815-4
-
Denmark
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
237-158-7
13674-84-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
204-118-5
115-96-8
Denmark
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
237-159-2
13674-87-8
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
EDA
203-468-6
107-15-3
ECHA
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
13/10/2016
Details
201-143-3
78-79-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
07/11/2016
Details
201-067-0
77-90-7
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/11/2016
Details
231-150-7
7440-41-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
19/12/2016
Details
215-204-7
1313-27-5
Denmark
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
19/12/2016
Details
232-089-9
7785-87-7
Denmark
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
12/01/2017
Details
205-355-7
139-13-9
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
12/01/2017
Details
203-625-9
108-88-3
Denmark
Mutagenic
Toxic for reproduction
Widespread use
Concluded
No need to initiate further regulatory risk management action at this time
None
12/01/2017
Details
234-323-5
11099-02-8
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
02/02/2017
Details
232-104-9
7786-81-4
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
02/02/2017
Details
-
-
Sweden
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
02/02/2017
Details

Export search results to:

Categories Display


Route: .live2